Format

Send to:

Choose Destination

lifitegrast [Supplementary Concept]

An LFA-1 (LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1) antagonist that is used in the treatment of DRY EYE SYNDROMES.

Date introduced: September 25, 2012

MeSH Unique ID: C575157

Registry Number: 038E5L962W

Heading Mapped to:

Entry Terms:

  • (2S)-2-(((2-(benzofuran-6-ylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinolin-6- yl)carbonyl)amino)-3-(3-(methylsulfonyl)phenyl)propanoic acid
  • L-phenylalanine, n-((2-(6-benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl)carbonyl)-3-(methylsulfonyl)-
  • SHP-606
  • SHP606
  • Xiidra
  • SAR 1118
  • SAR-1118

Pharmacologic Action:

Supplemental Content

Loading ...
Support Center